News
Chiltern Data and Analysis Team Making 12 Presentations at PharmaSUG 2016
Chiltern, a leading global clinical research organization, had 11 presentations and a poster accepted at PharmaSUG 2016, in Denver May 8-11.
“Having so many abstracts accepted for presentations showcases Chiltern’s depth of thought leadership,” said Jim Esinhart, PhD, Chiltern CEO. “Our data and analysis team is one of the largest and most experienced groups in the industry.”
Chiltern presentations at PharmaSUG include:
- BB16: UTF What? A Guide to Using UTF-8 Encoded Data in a SDTM Submission, Michael Stackhouse
- CP03: Are You Thinking About Becoming an Independent Contractor? Things to Consider as You Plan for Your New Entrepreneurship, Kathy Bradrick
- DS02: Tips and Tricks When Developing Trial Design Model Specifications that Provide Reductions in Creation Time, Ruth Marisol Rivera Barragan
- DS04: Moving Up! – SDTM 3.2 – What is New and How to Use It, Alyssa Wittle, Tony Cardozo, Christine McNichol
- DS10: Associated Persons Domains – Who, What, Where, When, Why, How? Stackhouse, Wittle
- Demonstration – DT27: Chiltern – Designed Around You, Jeff Sharp
- IB10: Moving from Data Collection to Data Visualization and Analytics: Leveraging CDISC SDTM Standards to Support Data Marts, Steve Kirby, Terek Peterson
- Digital poster – PO12: CDISC Standards End-to-End: Transitional Hurdles, McNichol, Wittle, Cardozo
- SS04: To IDB or Not to IDB: That is the Question, Beth Seremula
- SS09: Achieving Clarity Through Proper Study Documentation: An Introduction to the Study Data Reviewer’s Guide (SDRG), Stackhouse, Peterson
- TT05: Generalized Problem-Solving Techniques for De-bugging and Diagnosing Logic Errors, Tracy Sherman
- TT10: May the Function Be With You: Helpful SAS Functions, Particularly When Handling CDISC Data, Angela Lamb
Visit Chiltern in Booth 32 to discuss current or upcoming projects with the data and analysis team. The Chiltern recruitment team will also be available.
About Chiltern
Chiltern, a global contract research organization, is the leading mid-sized provider of clinical solutions in a variety of specialty areas and engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,200, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance, Strategic Regulatory and Clinical Supplies services using a collaborative approach to maximize efficiency and minimize delays. Visit Chiltern.com to learn more about how Chiltern is Designed Around You®.